戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ated with extreme inflammatory responses and disseminated intravascular coagulation.
2  was no chemical or microscopic evidence for disseminated intravascular coagulation.
3 ter infection, a full day after the onset of disseminated intravascular coagulation.
4 in-induced thrombosis, and endotoxin-induced disseminated intravascular coagulation.
5 ave value in the treatment of sepsis-induced disseminated intravascular coagulation.
6 eiving anticoagulants fulfilled criteria for disseminated intravascular coagulation.
7 l involvement with respiratory compromise or disseminated intravascular coagulation.
8 habdomyolysis, pneumonia, renal failure, and disseminated intravascular coagulation.
9 y including atherosclerosis, vasculitis, and disseminated intravascular coagulation.
10           Death was attributed to sepsis and disseminated intravascular coagulation.
11 ay contribute to local fibrin deposition and disseminated intravascular coagulation.
12 , including atherosclerosis, vasculitis, and disseminated intravascular coagulation.
13 vated monocytes in several diseases leads to disseminated intravascular coagulation.
14    There was no evidence of the induction of disseminated intravascular coagulation.
15 nt role in the pathophysiology of sepsis and disseminated intravascular coagulation.
16 antly, arguing against an important role for disseminated intravascular coagulation.
17                            Five patients had disseminated intravascular coagulation.
18  and/or regional microthrombosis rather than disseminated intravascular coagulation.
19 e (</= 58%; odds ratio, 0.98; p < 0.05) with disseminated intravascular coagulation.
20 sis and concurrent hepatobiliary dysfunction/disseminated intravascular coagulation.
21 ivation associated with septic shock-induced disseminated intravascular coagulation.
22 es are relevant biomarkers of sepsis-induced disseminated intravascular coagulation.
23 e lacking TFPI (Tfpi(-/-)) die in utero from disseminated intravascular coagulation.
24 both biochemical and microscopic evidence of disseminated intravascular coagulation.
25 phyxia induces bleeding by hyperfibrinolytic disseminated intravascular coagulation.
26 been used for treatment of sepsis-associated disseminated intravascular coagulation.
27 cally ill patients with sepsis and suspected disseminated intravascular coagulation.
28  in sepsis-associated coagulopathy including disseminated intravascular coagulation.
29 nfections are at a higher risk of developing disseminated intravascular coagulation.
30   During endotoxemia, TF expression leads to disseminated intravascular coagulation.
31 openia, transient leucopenia, and aggressive disseminated intravascular coagulation.
32 lants can be effective in severe sepsis with disseminated intravascular coagulation.
33 dothelial damage, leading to acute death and disseminated intravascular coagulation.
34 iltrates and lung injury, renal failure, and disseminated intravascular coagulation.
35 hagocytosis (70%), leukemia cutis (58%), and disseminated intravascular coagulation (39%) occurred fr
36 oderate to severe renal insufficiency (53%), disseminated intravascular coagulation (45%), and the ac
37                     Thirty-five patients had disseminated intravascular coagulation according to Japa
38 io = 2.01; 95% CI 1.12-3.59; p = 0.019), and disseminated intravascular coagulation (adjusted odds ra
39  several major clinical disorders, including disseminated intravascular coagulation and acute ischemi
40 nt at admission could predict the absence of disseminated intravascular coagulation and allow a bette
41 in inhibition is associated with less severe disseminated intravascular coagulation and better overal
42 ce of thrombotic complications, particularly disseminated intravascular coagulation and deep vein thr
43 inoic acid and chemotherapy, but developed a disseminated intravascular coagulation and died before c
44 coccal sepsis that moderates the severity of disseminated intravascular coagulation and enables host
45                          However, except for disseminated intravascular coagulation and hypercalcemia
46 M173 pathway correlates with the severity of disseminated intravascular coagulation and mortality in
47 of NET formation could independently predict disseminated intravascular coagulation and mortality, wh
48 rse the lethal sequelae of sepsis, including disseminated intravascular coagulation and multi-organ f
49                              Measurements in disseminated intravascular coagulation and no disseminat
50 ay contribute to the hemostatic imbalance in disseminated intravascular coagulation and other coagulo
51 condary endpoints included reversal of overt disseminated intravascular coagulation and reduction in
52  activation of proteolytic cascades, such as disseminated intravascular coagulation and sepsis, acqui
53 ptoms due to hemorrhage, possibly because of disseminated intravascular coagulation and/or hemophagoc
54  Sequential Organ Failure Assessment scores, disseminated intravascular coagulation, and 28-day morta
55 d is associated with venous thromboembolism, disseminated intravascular coagulation, and additional c
56  VTE patients, for diagnosing and monitoring disseminated intravascular coagulation, and as an aid in
57 ogenic mechanisms in infective endocarditis, disseminated intravascular coagulation, and cardiovascul
58 , liver dysfunction, coagulopathy resembling disseminated intravascular coagulation, and extreme hype
59 utrophil extracellular trap (NET) induction, disseminated intravascular coagulation, and inflammation
60 cluding acute respiratory distress syndrome, disseminated intravascular coagulation, and multiorgan f
61 plantation, cardiac arrhythmias, presence of disseminated intravascular coagulation, and need for vas
62 ft ventricular failure with pulmonary edema, disseminated intravascular coagulation, and neurologic i
63 e observed changes in vascular permeability, disseminated intravascular coagulation, and systemic inf
64 es to collapse of the circulatory system, to disseminated intravascular coagulation, and to a 30% mor
65 ailure, acute respiratory distress syndrome, disseminated intravascular coagulation, and, rarely, dea
66 le organ dysfunction, neurologic injury, and disseminated intravascular coagulation are common compli
67 at admission is predictive of the absence of disseminated intravascular coagulation (area under the c
68  of concurrent hepatobiliary dysfunction and disseminated intravascular coagulation as features of ma
69 n in patients with sepsis, septic shock, and disseminated intravascular coagulation associated with i
70                        One child died due to disseminated intravascular coagulation associated with p
71 ts had a 13 times higher prevalence of overt disseminated intravascular coagulation at admission (55%
72                                Sixty-one had disseminated intravascular coagulation at admission, and
73 so analyzed after exclusion of patients with disseminated intravascular coagulation at admission.
74 se of intrapartum convulsion and one case of disseminated intravascular coagulation (both in the Fole
75 n the setting of sepsis may not be caused by disseminated intravascular coagulation but instead repor
76 nduced systemic proinflammatory response and disseminated intravascular coagulation, by reducing the
77                  Intravascular thrombosis or disseminated intravascular coagulation can also occur in
78 -derived microparticles were associated with disseminated intravascular coagulation: CD105-microparti
79 rrogates of cell activation to improve early disseminated intravascular coagulation diagnosis and pat
80 ty of 90.91% and a specificity of 80.60% for disseminated intravascular coagulation diagnosis.
81  newly diagnosed AML, we assessed markers of disseminated intravascular coagulation (DIC) (fibrinogen
82                 Pulmonary xenografts develop disseminated intravascular coagulation (DIC) and microva
83 during disease was determined by scoring for disseminated intravascular coagulation (DIC) and recordi
84 inflammation in animal models of sepsis with disseminated intravascular coagulation (DIC) and that co
85 agnosed because of overlapping features with disseminated intravascular coagulation (DIC) and the lac
86 ed coagulation system with increased risk of disseminated intravascular coagulation (DIC) and venous
87 ed coagulation system with increased risk of disseminated intravascular coagulation (DIC) and venous
88                                              Disseminated intravascular coagulation (DIC) appears to
89 on, prevent ischemia-reperfusion injury, and disseminated intravascular coagulation (DIC) associated
90           Work toward a better definition of disseminated intravascular coagulation (DIC) by characte
91 were compared with the aim to investigate if disseminated intravascular coagulation (DIC) could be su
92                                              Disseminated intravascular coagulation (DIC) has been ob
93 n coagulopathy with histological evidence of disseminated intravascular coagulation (DIC) in four.
94 ed using: (1) a carrageenan-induced model of disseminated intravascular coagulation (DIC) in mice; (2
95  activated platelets in inflammation-induced disseminated intravascular coagulation (DIC) in micro-ca
96         Reports of widespread thromboses and disseminated intravascular coagulation (DIC) in patients
97                                              Disseminated intravascular coagulation (DIC) is a comple
98                                              Disseminated intravascular coagulation (DIC) is a condit
99                                              Disseminated intravascular coagulation (DIC) is a freque
100                                            A disseminated intravascular coagulation (DIC) picture may
101 scribe high venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) rates, but
102 e looked at the utility of a simple evolving disseminated intravascular coagulation (DIC) score that
103                           No signs of severe disseminated intravascular coagulation (DIC) were observ
104             However, other processes such as disseminated intravascular coagulation (DIC), hyperfibri
105  Group 1 and 2 animals developed features of disseminated intravascular coagulation (DIC), with reduc
106                                              Disseminated intravascular coagulation (DIC)-positive ki
107 omplications of hemoglobinemia, particularly disseminated intravascular coagulation (DIC).
108 coagulation system leads to life-threatening disseminated intravascular coagulation (DIC).
109 y followed by vessel obstruction may lead to disseminated intravascular coagulation (DIC).
110 y, mortality, and laboratory consequences of disseminated intravascular coagulation (DIC).
111 asma levels of endothelial glycoproteins and disseminated intravascular coagulation (DIC).
112 racterized by a highly thrombotic subtype of disseminated intravascular coagulation (DIC).
113 ly leading to bleeding tendencies similar to disseminated intravascular coagulation (DIC).
114 ion tree for patients with sepsis-associated disseminated intravascular coagulation (DIC).
115        The typical laboratory pattern mimics disseminated intravascular coagulation (DIC).
116 days) in platelet counts and fibrinogen with disseminated intravascular coagulation (DIC); after graf
117 ession of human Pdpn-Fc in mouse skin causes disseminated intravascular coagulation due to platelet a
118 receptor moderates the onset and severity of disseminated intravascular coagulation during sepsis and
119 t of treatment, may limit the development of disseminated intravascular coagulation during systemic i
120 r coagulation at admission, and 32 developed disseminated intravascular coagulation during the first
121 epsy, appendicitis, immune thrombocytopenia, disseminated intravascular coagulation, encephalomyeliti
122            The non-hepatobiliary dysfunction/disseminated intravascular coagulation group included pa
123                                              Disseminated intravascular coagulation had the largest d
124   Although blood coagulation changes such as disseminated intravascular coagulation have been recogni
125                    Although septic shock and disseminated intravascular coagulation have been reporte
126 ation syndrome, a similar entity with fever, disseminated intravascular coagulation, hepatobiliary dy
127 , hemophagocytosis, hyperfibrinogenemia with disseminated intravascular coagulation, hypertriglycerid
128                                              Disseminated intravascular coagulation, immune thrombocy
129 us disease 2019 patients (COVID-19) and with disseminated intravascular coagulation in cancer patient
130 one of the significant mechanisms underlying disseminated intravascular coagulation in EHF patients.
131       Characterization of null fish revealed disseminated intravascular coagulation in larvae seconda
132 al growth factor, complement activation, and disseminated intravascular coagulation in one or more he
133  be a causative agent in the pathogenesis of disseminated intravascular coagulation in sepsis.
134 is sometimes encountered in association with disseminated intravascular coagulation in the donor, and
135 al sampling experiments revealed evidence of disseminated intravascular coagulation in the livers of
136 g4) mice, mainly reflecting earlier signs of disseminated intravascular coagulation in this latter co
137 t microvascular endothelial stress (nonovert disseminated intravascular coagulation) in patients who
138 r, splenomegaly, bleeding, fever, infection, disseminated intravascular coagulation, increasing heigh
139  cause, among other symptoms, hemorrhage and disseminated intravascular coagulation, indicating a rol
140      In primate models of sepsis, APC blocks disseminated intravascular coagulation initiated by Esch
141 tress in which there is no evidence of overt disseminated intravascular coagulation, injury of the en
142                                              Disseminated intravascular coagulation is a prominent ma
143                  These results indicate that disseminated intravascular coagulation is an early and i
144 of coagulation, which can culminate in overt disseminated intravascular coagulation, is a prominent f
145 ble thrombomodulin, activated protein C, and disseminated intravascular coagulation markers.
146 ing times, and tissue factor- or LPS-induced disseminated intravascular coagulation models, no signif
147 ssed children with septic shock and signs of disseminated intravascular coagulation, more than 60% of
148 ress to acute respiratory distress syndrome, disseminated intravascular coagulation, multisystem fail
149 fever, neither delayed blood coagulation and disseminated intravascular coagulation nor death from sh
150                                              Disseminated intravascular coagulation occurred in 11 pa
151 bility, excessive bleeding in the setting of disseminated intravascular coagulation or other states o
152                     There was no evidence of disseminated intravascular coagulation or renal dysfunct
153 eased odds of severe preeclampsia, embolism, disseminated intravascular coagulation or shock, cerebro
154 uch as liver dysfunction, medication effect, disseminated intravascular coagulation, or certain vitam
155 ts with only hepatobiliary dysfunction, only disseminated intravascular coagulation, or neither.
156 ng patients develops overt hyperfibrinolytic disseminated intravascular coagulation, partly caused by
157 y survival rate in hepatobiliary dysfunction/disseminated intravascular coagulation patients (65.4% a
158 lacebo-treated non-hepatobiliary dysfunction/disseminated intravascular coagulation patients (71.4% v
159 isseminated intravascular coagulation and no disseminated intravascular coagulation patients showed t
160  deep venous thrombosis, pulmonary embolism, disseminated intravascular coagulation, portal vein thro
161 ch as leukostasis, tumor lysis syndrome, and disseminated intravascular coagulation put the patient a
162 ebrile neutropenia, transient and reversible disseminated intravascular coagulation related to rituxi
163 e interval 1.2-4.7; p = .035) and have overt disseminated intravascular coagulation (relative risk 4.
164 e serious sequelae including hemoglobinemia, disseminated intravascular coagulation, renal failure, a
165                           Despite comparable disseminated intravascular coagulation scores, acute pro
166 oinflammatory condition that can manifest as disseminated intravascular coagulation, septic shock, an
167 tions were sicker and more likely to develop disseminated intravascular coagulation than patients wit
168             One procedure was complicated by disseminated intravascular coagulation that necessitated
169 lect a vascular injury during sepsis-induced disseminated intravascular coagulation that precedes obv
170  of a fVII immunoconjugate to TF might cause disseminated intravascular coagulation, the active site
171 odstream during infection is associated with disseminated intravascular coagulation, the mechanistic
172  levels of PC predispose mice to early-onset disseminated intravascular coagulation, thrombocytopenia
173                                Prediction of disseminated intravascular coagulation was also analyzed
174                                              Disseminated intravascular coagulation was diagnosed acc
175         Concurrent hepatobiliary dysfunction/disseminated intravascular coagulation was noted in 43 p
176                                  Evidence of disseminated intravascular coagulation was noted; howeve
177                              In two baboons, disseminated intravascular coagulation was successfully
178  CRS may develop capillary leak syndrome and disseminated intravascular coagulation, with a cytokine
179 th drowning-induced asphyxia developed overt disseminated intravascular coagulation within 24 hours.
180 epsis may therefore limit the development of disseminated intravascular coagulation without increasin

 
Page Top